NEWS RELEASE |
4Q18 3 months ended 03/31/18 | 3Q18 3 months ended 12/31/17 | + increase / - decrease | FY18 12 months ended 03/31/18 | FY17 12 months ended 03/31/17 | + increase / - decrease | ||
Revenue | $11.1M | $13.7M | -$2.6M | $58.6M | $63.0M | -$4.4M | |
Gross Margin | 45.5% | 44.4% | +1.1% | 43.0% | 37.7% | +5.3% | |
Operating Margin | -8.5% | 0.3% | -8.8% | -2.5% | -25.5% | +23.0% | |
Net Income | -$0.9M | $0.8M | -$1.7M | $— | -$15.9M | +$15.9M | |
Earnings Per Share | -$0.06 | $0.05 | -$0.11 | $0.00 | -$1.04 | +$1.04 | |
Non-GAAP Operating Margin (1) | +3.5% | +10.2% | -6.7% | +7.1% | -5.6% | +12.7% | |
Non-GAAP Net Income (1) | $0.4M | $1.5M | -$1.1M | $4.4M | -$3.4M | +$7.8M | |
Non-GAAP Earnings Per Share (1) | $0.03 | $0.09 | -$0.06 | $0.28 | -$0.22 | +$0.50 | |
Non-GAAP Adjusted EBITDA (1) | $0.6M | $1.6M | -$1.0M | $4.9M | -$2.1M | +$7.0M | |
Ending Cash & ST Investments | $27.7M | $26.0M | +$1.7M | $27.7M | $21.8M | +$5.9M | |
(1) Please refer to the schedule at the end of this press release for a complete GAAP to non-GAAP reconciliation and other information related to non-GAAP financial measures. |
4Q18 3 months ended 03/31/18 | 3Q18 3 months ended 12/31/17 | + increase / - decrease | FY18 12 months ended 03/31/18 | FY17 12 months ended 03/31/17 | + increase / - decrease | ||
IBW Segment Revenue | $3.2M | $5.2M | -$2.0M | $23.3M | $25.9M | -$2.6M | |
IBW Segment Gross Margin | 48.0% | 47.3% | +0.7% | 45.8% | 33.4% | +12.4% | |
IBW Segment R&D Expense | $0.5M | $0.8M | -$0.3M | $4.1M | $6.7M | -$2.6M | |
IBW Segment Profit | $1.0M | $1.7M | -$0.7M | $6.5M | $1.9M | $4.6M |
4Q18 3 months ended 03/31/18 | 3Q18 3 months ended 12/31/17 | + increase / - decrease | FY18 12 months ended 03/31/18 | FY17 12 months ended 03/31/17 | + increase / - decrease | ||
ISMS Segment Revenue | $4.7M | $5.8M | -$1.1M | $19.4M | $19.3M | $0.1M | |
ISMS Segment Gross Margin | 52.3% | 54.5% | -2.2% | 51.5% | 50.6% | +0.9% | |
ISMS Segment R&D Expense | $0.6M | $0.5M | $0.1M | $2.3M | $4.0M | -$1.7M | |
ISMS Segment Profit | $1.8M | $2.6M | -$0.8M | $7.7M | $5.8M | $1.9M |
4Q18 3 months ended 03/31/18 | 3Q18 3 months ended 12/31/17 | + increase / - decrease | FY18 12 months ended 03/31/18 | FY17 12 months ended 03/31/17 | + increase / - decrease | ||
CNS Segment Revenue | $3.2M | $2.7M | $0.5M | $16.0M | $17.7M | -$1.7M | |
CNS Segment Gross Margin | 33.2% | 16.9% | +16.3% | 28.5% | 29.9% | -1.4% | |
CNS Segment R&D Expense | $0.2M | $0.2M | $— | $1.0M | $1.7M | -$0.7M | |
CNS Segment Profit | $0.8M | $0.2M | $0.6M | $3.6M | $3.6M | $— |
Three months ended | Twelve months ended | ||||||||||||||||||||
March 31, 2018 (Unaudited) | December 31, 2017 (Unaudited) | March 31, 2017 (Unaudited) | March 31, 2018 (Unaudited) | March 31, 2017 (Audited) | |||||||||||||||||
Revenue: | |||||||||||||||||||||
Products | $ | 10,063 | $ | 11,754 | $ | 14,290 | $ | 53,459 | $ | 56,530 | |||||||||||
Services | 1,033 | 1,921 | 1,096 | 5,118 | 6,435 | ||||||||||||||||
Total revenue | $ | 11,096 | $ | 13,675 | $ | 15,386 | $ | 58,577 | $ | 62,965 | |||||||||||
Cost of revenue: | |||||||||||||||||||||
Products | 5,769 | 7,114 | 8,331 | 31,829 | 36,119 | ||||||||||||||||
Services | 278 | 485 | 292 | 1,581 | 3,097 | ||||||||||||||||
Total cost of revenue | 6,047 | 7,599 | 8,623 | 33,410 | 39,216 | ||||||||||||||||
Gross profit | 5,049 | 6,076 | 6,763 | 25,167 | 23,749 | ||||||||||||||||
Gross margin | 45.5 | % | 44.4 | % | 44.0 | % | 43.0 | % | 37.7 | % | |||||||||||
Operating expenses: | |||||||||||||||||||||
Research & development | 1,352 | 1,542 | 2,349 | 7,375 | 12,367 | ||||||||||||||||
Sales & marketing | 2,012 | 1,950 | 2,124 | 8,290 | 10,344 | ||||||||||||||||
General & administrative | 1,580 | 1,502 | 1,651 | 6,602 | 7,991 | ||||||||||||||||
Intangibles amortization | 1,047 | 1,047 | 1,151 | 4,189 | 4,764 | ||||||||||||||||
Restructuring | — | — | 100 | (1) | 165 | (2) | 3,155 | (1) | |||||||||||||
Long-lived assets impairment | — | — | — | — | 1,181 | (3) | |||||||||||||||
Total operating expenses | 5,991 | 6,041 | 7,375 | 26,621 | 39,802 | ||||||||||||||||
Operating income (loss) | (942 | ) | 35 | (612 | ) | (1,454 | ) | (16,053 | ) | ||||||||||||
Other income (expense), net | 89 | 79 | 94 | 888 | (4) | 170 | |||||||||||||||
Income (loss) before income taxes | (853 | ) | 114 | (518 | ) | (566 | ) | (15,883 | ) | ||||||||||||
Income tax benefit (expense) | (63 | ) | 685 | (5) | (38 | ) | 597 | (5) | (58 | ) | |||||||||||
Net income (loss) | $ | (916 | ) | $ | 799 | $ | (556 | ) | $ | 31 | $ | (15,941 | ) | ||||||||
Net income (loss) per share: | |||||||||||||||||||||
Basic net income (loss) | $ | (0.06 | ) | $ | 0.05 | $ | (0.04 | ) | (6) | $ | 0.00 | $ | (1.04 | ) | (6) | ||||||
Diluted net income (loss) | $ | (0.06 | ) | $ | 0.05 | $ | (0.04 | ) | (6) | $ | 0.00 | $ | (1.04 | ) | (6) | ||||||
Weighted-average number of shares outstanding: | |||||||||||||||||||||
Basic | 15,541 | 15,504 | 15,431 | (6) | 15,497 | 15,344 | (6) | ||||||||||||||
Diluted | 15,541 | 15,755 | 15,431 | (6) | 15,707 | 15,344 | (6) |
Assets: | March 31, 2018 (Unaudited) | March 31, 2017 (Audited) | |||||||
Cash and cash equivalents | $ | 24,963 | $ | 21,778 | |||||
Short-term investments | 2,779 | 0 | |||||||
Accounts receivable, net | 8,872 | 12,075 | |||||||
Inventories | 9,222 | 12,511 | |||||||
Prepaid expenses and other current assets | 816 | 1,409 | |||||||
Total current assets | 46,652 | 47,773 | |||||||
Property and equipment, net | 1,601 | 1,984 | |||||||
Intangible assets, net | 11,435 | 15,624 | |||||||
Other non-current assets | 771 | 160 | |||||||
Total assets | $ | 60,459 | $ | 65,541 | |||||
Liabilities and Stockholders’ Equity: | |||||||||
Accounts payable | $ | 1,903 | $ | 4,163 | |||||
Accrued expenses | 3,328 | 4,273 | |||||||
Accrued restructuring | 63 | 1,171 | |||||||
Deferred revenue | 1,790 | 2,359 | |||||||
Total current liabilities | 7,084 | 11,966 | |||||||
Deferred revenue non-current | 846 | 1,102 | |||||||
Accrued restructuring non-current | — | 63 | |||||||
Other non-current liabilities | 234 | 236 | |||||||
Total liabilities | 8,164 | 13,367 | |||||||
Total stockholders’ equity | 52,295 | 52,174 | |||||||
Total liabilities and stockholders’ equity | $ | 60,459 | $ | 65,541 |
Three months ended March 31, | Twelve months ended March 31, | |||||||||||
Cash flows from operating activities: | 2018 (Unaudited) | 2018 (Unaudited) | 2017 (Audited) | |||||||||
Net income (loss) | $ | (916 | ) | $ | 31 | $ | (15,941 | ) | ||||
Reconciliation of net income to net cash provided by (used in) operating activities: | ||||||||||||
Depreciation and amortization | 1,210 | 4,957 | 6,144 | |||||||||
Long-lived assets impairment | — | — | 1,181 | |||||||||
Stock-based compensation | 283 | 1,271 | 1,594 | |||||||||
Restructuring | — | 165 | 3,155 | |||||||||
Gain on disposal of foreign operations | — | (608 | ) | — | ||||||||
Deferred taxes | — | (697 | ) | (10 | ) | |||||||
Loss (gain) on sale of fixed assets | 12 | 22 | 27 | |||||||||
Exchange rate loss (gain) | 22 | 2 | 2 | |||||||||
Changes in assets and liabilities: | ||||||||||||
Accounts receivable | 2,175 | 3,200 | 4,281 | |||||||||
Inventories | 242 | 3,289 | 987 | |||||||||
Accounts payable and accrued expenses | (999 | ) | (4,541 | ) | (9,570 | ) | ||||||
Deferred revenue | (207 | ) | (825 | ) | 624 | |||||||
Prepaid expenses and other current assets | 48 | 593 | 491 | |||||||||
Other asset | 6 | 86 | 24 | |||||||||
Net cash provided by (used in) operating activities | 1,876 | 6,945 | (7,011 | ) | ||||||||
Cash flows from investing activities: | ||||||||||||
Net purchases of short-term investments and debt securities | 1,758 | (2,779 | ) | 10,555 | ||||||||
Proceeds from sale of assets | 2 | 2 | — | |||||||||
Purchases of property and equipment | (147 | ) | (408 | ) | (596 | ) | ||||||
Net cash provided by (used in) investing activities | 1,613 | (3,185 | ) | 9,959 | ||||||||
Cash flows from financing activities: | ||||||||||||
Payment of contingent consideration | — | — | (175 | ) | ||||||||
Purchases of treasury stock | (16 | ) | (574 | ) | (163 | ) | ||||||
Net cash provided by (used in) financing activities | (16 | ) | (574 | ) | (338 | ) | ||||||
Gain (loss) of exchange rate changes on cash | (2 | ) | (1 | ) | (1 | ) | ||||||
Net increase (decrease) in cash and cash equivalents | 3,471 | 3,185 | 2,609 | |||||||||
Cash and cash equivalents, beginning of period | 21,492 | 21,778 | 19,169 | |||||||||
Cash and cash equivalents, end of period | $ | 24,963 | $ | 24,963 | $ | 21,778 |
Three months ended March 31, 2018 | Three months Ended December 31, 2017 | |||||||||||||||||||||||||||||||
IBW | ISMS | CNS | Total | IBW | ISMS | CNS | Total | |||||||||||||||||||||||||
Revenue | $ | 3,167 | $ | 4,688 | $ | 3,241 | $ | 11,096 | $ | 5,223 | $ | 5,802 | $ | 2,650 | $ | 13,675 | ||||||||||||||||
Gross profit | 1,520 | 2,454 | 1,075 | 5,049 | 2,469 | 3,160 | 447 | 6,076 | ||||||||||||||||||||||||
Gross margin | 48.0 | % | 52.3 | % | 33.2 | % | 45.5 | % | 47.3 | % | 54.5 | % | 16.9 | % | 44.4 | % | ||||||||||||||||
R&D expense | 485 | 629 | 238 | 1,352 | 750 | 547 | 245 | 1,542 | ||||||||||||||||||||||||
Segment profit | $ | 1,035 | $ | 1,825 | $ | 837 | $ | 3,697 | $ | 1,719 | $ | 2,613 | $ | 202 | $ | 4,534 |
Three months ended March 31, 2018 | Three months ended March 31, 2017 | |||||||||||||||||||||||||||||||
IBW | ISMS | CNS | Total | IBW | ISMS | CNS | Total | |||||||||||||||||||||||||
Revenue | $ | 3,167 | $ | 4,688 | $ | 3,241 | $ | 11,096 | $ | 6,944 | $ | 4,548 | $ | 3,894 | $ | 15,386 | ||||||||||||||||
Gross profit | 1,520 | 2,454 | 1,075 | 5,049 | 2,933 | 2,557 | 1,273 | 6,763 | ||||||||||||||||||||||||
Gross margin | 48.0 | % | 52.3 | % | 33.2 | % | 45.5 | % | 42.2 | % | 56.2 | % | 32.7 | % | 44.0 | % | ||||||||||||||||
R&D expense | 485 | 629 | 238 | 1,352 | 1,473 | 619 | 257 | 2,349 | ||||||||||||||||||||||||
Segment profit | $ | 1,035 | $ | 1,825 | $ | 837 | $ | 3,697 | $ | 1,460 | $ | 1,938 | $ | 1,016 | $ | 4,414 |
Twelve months ended March 31, 2018 | Twelve months ended March 31, 2017 | |||||||||||||||||||||||||||||||
IBW | ISMS | CNS | Total | IBW | ISMS | CNS | Total | |||||||||||||||||||||||||
Revenue | $ | 23,265 | $ | 19,350 | $ | 15,962 | $ | 58,577 | $ | 25,933 | $ | 19,321 | $ | 17,711 | $ | 62,965 | ||||||||||||||||
Gross profit | 10,653 | 9,959 | 4,555 | 25,167 | 8,671 | 9,778 | 5,300 | 23,749 | ||||||||||||||||||||||||
Gross margin | 45.8 | % | 51.5 | % | 28.5 | % | 43.0 | % | 33.4 | % | 50.6 | % | 29.9 | % | 37.7 | % | ||||||||||||||||
R&D expense | 4,141 | 2,264 | 970 | 7,375 | 6,738 | 3,955 | 1,674 | 12,367 | ||||||||||||||||||||||||
Segment profit | $ | 6,512 | $ | 7,695 | $ | 3,585 | $ | 17,792 | $ | 1,933 | $ | 5,823 | $ | 3,626 | $ | 11,382 |
Twelve months ended March 31, 2018 | Twelve months ended March 31, 2017 | |||||||||||||||||||||
Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | |||||||||||||||||
GAAP - IBW segment | $ | 23,265 | $ | 10,653 | 45.8 | % | $ | 25,933 | $ | 8,671 | 33.4 | % | ||||||||||
ClearLink DAS E&O (1) | — | — | — | 1,581 | ||||||||||||||||||
Stock-based compensation (2) | — | 5 | — | 9 | ||||||||||||||||||
Non-GAAP - IBW segment | $ | 23,265 | $ | 10,658 | 45.8 | % | $ | 25,933 | $ | 10,261 | 39.6 | % | ||||||||||
(1) Excess and Obsolete inventory charges on ClearLink DAS inventory and firm purchase commitments. | ||||||||||||||||||||||
(2) Stock-based compensation is a non-cash expense incurred in accordance with share-based compensation accounting standards. |
Three months ended March 31, 2018 | Three months ended December 31, 2017 | Three months ended March 31, 2017 | |||||||||||||||||||||||||||||||
Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | |||||||||||||||||||||||||
GAAP - Consolidated | $ | 11,096 | $ | 5,049 | 45.5 | % | $ | 13,675 | $ | 6,076 | 44.4 | % | $ | 15,386 | $ | 6,763 | 44.0 | % | |||||||||||||||
Deferred revenue adjustment (1) | — | — | — | — | 64 | 64 | |||||||||||||||||||||||||||
Stock-based compensation (2) | — | (3 | ) | — | 11 | — | 10 | ||||||||||||||||||||||||||
Non-GAAP - Consolidated | $ | 11,096 | $ | 5,046 | 45.5 | % | $ | 13,675 | $ | 6,087 | 44.5 | % | $ | 15,450 | $ | 6,837 | 44.3 | % |
Twelve months ended March 31, 2018 | Twelve months ended March 31, 2017 | |||||||||||||||||||||
Revenue | Gross Profit | Gross Margin | Revenue | Gross Profit | Gross Margin | |||||||||||||||||
GAAP - Consolidated | $ | 58,577 | $ | 25,167 | 43.0 | % | $ | 62,965 | $ | 23,749 | 37.7 | % | ||||||||||
Deferred revenue adjustment (1) | — | — | 254 | 254 | ||||||||||||||||||
Stock-based compensation (2) | — | 30 | — | 34 | ||||||||||||||||||
ClearLink DAS E&O (3) | — | — | — | 1,581 | ||||||||||||||||||
Non-GAAP - Consolidated | $ | 58,577 | $ | 25,167 | 43.0 | % | $ | 63,219 | $ | 25,618 | 40.5 | % |
Three months ended | Twelve months ended | |||||||||||||||||||
March 31, | December 31, | March 31, | March 31, | March 31, | ||||||||||||||||
2018 | 2017 | 2017 | 2018 | 2017 | ||||||||||||||||
GAAP consolidated operating expenses | $ | 5,991 | $ | 6,041 | $ | 7,375 | $ | 26,621 | $ | 39,802 | ||||||||||
Adjustments: | ||||||||||||||||||||
Stock-based compensation (2) | (286 | ) | (305 | ) | (238 | ) | (1,241 | ) | (1,560 | ) | ||||||||||
Long-lived asset impairment (4) | — | — | — | — | (1,181 | ) | ||||||||||||||
Amortization of intangibles (5) | (1,047 | ) | (1,047 | ) | (1,151 | ) | (4,189 | ) | (4,764 | ) | ||||||||||
Restructuring, separation, and transition (6) | — | — | (100 | ) | (165 | ) | (3,155 | ) | ||||||||||||
Total adjustments | (1,333 | ) | (1,352 | ) | (1,489 | ) | (5,595 | ) | (10,660 | ) | ||||||||||
Non-GAAP consolidated operating expenses | $ | 4,658 | $ | 4,689 | $ | 5,886 | $ | 21,026 | $ | 29,142 |
Three months ended | Twelve months ended | ||||||||||||||||||||
March 31, | December 31, | March 31, | March 31, | March 31, | |||||||||||||||||
2018 | 2017 | 2017 | 2018 | 2017 | |||||||||||||||||
GAAP consolidated net income (loss) | $ | (916 | ) | $ | 799 | $ | (556 | ) | $ | 31 | $ | (15,941 | ) | ||||||||
Less: | |||||||||||||||||||||
Income tax benefit (expense) | (63 | ) | 685 | (38 | ) | 597 | (58 | ) | |||||||||||||
Other income (expense), net | 89 | 79 | 94 | 888 | 170 | ||||||||||||||||
GAAP consolidated operating profit (loss) | $ | (942 | ) | $ | 35 | $ | (612 | ) | $ | (1,454 | ) | $ | (16,053 | ) | |||||||
Adjustments: | |||||||||||||||||||||
Deferred revenue adjustment (1) | — | — | 64 | — | 254 | ||||||||||||||||
Stock-based compensation (2) | 283 | 316 | 248 | 1,271 | 1,594 | ||||||||||||||||
ClearLink DAS E&O (3) | — | — | — | — | 1,581 | ||||||||||||||||
Long-lived asset impairment (4) | — | — | — | — | 1,181 | ||||||||||||||||
Amortization of intangibles (5) | 1,047 | 1,047 | 1,151 | 4,189 | 4,764 | ||||||||||||||||
Restructuring, separation, and transition (6) | — | — | 100 | 165 | 3,155 | ||||||||||||||||
Total adjustments | 1,330 | — | 1,363 | 1,563 | 5,625 | 12,529 | |||||||||||||||
Non-GAAP consolidated operating profit (loss) | $ | 388 | $ | 1,398 | $ | 951 | $ | 4,171 | $ | (3,524 | ) | ||||||||||
Depreciation | 163 | 174 | 279 | 768 | 1,380 | ||||||||||||||||
Non-GAAP consolidated Adjusted EBITDA (7) | $ | 551 | $ | 1,572 | $ | 1,230 | $ | 4,939 | $ | (2,144 | ) |
Three months ended | Twelve months ended | |||||||||||||||||||
March 31, | December 31, | March 31, | March 31, | March 31, | ||||||||||||||||
2018 | 2017 | 2017 | 2018 | 2017 | ||||||||||||||||
GAAP consolidated net income (loss) | $ | (916 | ) | $ | 799 | $ | (556 | ) | $ | 31 | $ | (15,941 | ) | |||||||
Adjustments: | ||||||||||||||||||||
Deferred revenue adjustment (1) | — | — | 64 | — | 254 | |||||||||||||||
Stock-based compensation (2) | 283 | 316 | 248 | 1,271 | 1,594 | |||||||||||||||
ClearLink DAS E&O (3) | — | — | — | — | 1,581 | |||||||||||||||
Long-lived asset impairment (4) | — | — | — | — | 1,181 | |||||||||||||||
Amortization of intangibles (5) | 1,047 | 1,047 | 1,151 | 4,189 | 4,764 | |||||||||||||||
Restructuring, separation, and transition (6) | — | — | 100 | 165 | 3,155 | |||||||||||||||
Foreign currency translation adjustment (8) | — | — | — | (608 | ) | — | ||||||||||||||
Income taxes (9) | — | (697 | ) | — | (697 | ) | — | |||||||||||||
Total adjustments | 1,330 | 666 | 1,563 | 4,320 | 12,529 | |||||||||||||||
Non-GAAP consolidated net income (loss) | $ | 414 | $ | 1,465 | $ | 1,007 | $ | 4,351 | $ | (3,412 | ) | |||||||||
GAAP consolidated net income (loss) per common share: | ||||||||||||||||||||
Diluted | $ | (0.06 | ) | $ | 0.05 | $ | (0.04 | ) | $ | 0.00 | $ | (1.04 | ) | |||||||
Non-GAAP consolidated net income (loss) per common share: | ||||||||||||||||||||
Diluted | $ | 0.03 | $ | 0.09 | $ | 0.06 | $ | 0.28 | $ | (0.22 | ) | |||||||||
Average number of common shares outstanding: | ||||||||||||||||||||
Diluted | 15,794 | 15,755 | 15,528 | 15,707 | 15,344 |
Tom Minichiello Chief Financial Officer Westell Technologies, Inc. +1 (630) 375-4740 tminichiello@westell.com |